Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

PFE 33.67 -0.02 (-0.06%)
price chart
Verastem Acquires Clinical-Stage FAK Inhibitor from Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced an agreement with Pfizer for ...
Verastem Inks Separate Deals for Wnt and FAK Inhibitors  Genetic Engineering News
For Pfizer, Boston's medical labs a lure
Pfizer Inc., the world's largest pharmaceutical company, has a storied history of hunting for blockbuster drugs in its own labs.
Is Pfizer A Good Buy?
Pfizer has been involved in a series of acquisitions and sell offs, some cheered and some criticized by investors. They recently sold off their nutrition business to Nestle for $11.9 billion.
Pfizer yanks breast, colon claims for Centrum vitamins
"The company disagrees with CSPI's concerns, but has agreed to make these changes in order to fully resolve the issues raised by the organization," Pfizer said in a statement provided on Thursday. A company spokesman declined to elaborate when asked ...
Pfizer to remove "breast health" and "colon health" ...  CBS News
Centrum Drops Breast And Colon Health Claims Amid Deceptive Advertising ...  Huffington Post
Pfizer Announces Topline Results Of First Of Four Studies In Bapineuzumab ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC ...
Hopes dim for Alzheimer's trials after Pfizer failure  Reuters
Alzheimer's Drug Fails a Late-Stage Clinical Trial  TIME
Pfizer to return rights to three Acura products
Pfizer Inc will return three products it was developing using Acura Pharmaceuticals Inc's abuse-resistant technology, Acura said on Friday.
Pharmacies Sue Pfizer Over Lipitor
"We are confident that Pfizer's procurement and enforcement of its Lipitor patents was at all times proper and lawful," the company said. "The Lipitor patent settlements, including the settlement with Ranbaxy, were submitted for review by the U.S ...
Pfizer sued by retailers for generic Lipitor delay  Fox News
Retailers sue Pfizer, charge generic Lipitor delay  Inquirer.net
Travelers Sues Pfizer For $47M Over Epilepsy Drug
Law360, New York (July 18, 2012, 11:09 PM ET) -- Travelers Indemnity Co. and several of its affiliates on Wednesday filed a $47 million suit against Pfizer Inc. claiming they overpaid for epilepsy drug Neurontin because of its anti-competitive efforts ...
Pfizer Wins Patent Ruling, Exclusive Sales for Lyrica Drug
Pfizer Inc., the world's largest drugmaker, convinced a U.S. judge that its patents for the pain-drug Lyrica are valid and infringed, giving it exclusive sales rights until 2018.
Pfizer Wins Lyrica Patent Ruling  Wall Street Journal
Delaware district court upholds Pfizer's patents for LYRICA to treat ...  News-Medical.net
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.